Why the study?
Does the nucleoprotein complement-fixation test improve the detection of antinuclear antibodies in patients with systemic lupus erythematosus compared to the L.E.-cell test?
Does the nucleoprotein complement-fixation test improve the detection of antinuclear antibodies in patients with systemic lupus erythematosus compared to the L.E.-cell test?
The nucleoprotein complement-fixation test is discussed as a method for detecting antinuclear antibodies in systemic lupus erythematosus.
A gamma-globulin factor in the serum of patients with systemic lupus erythematosus that reacts with isolated cell nuclei1 or nucleoprotein2 , 3 has been detected in many ways.4 The standard method of demonstrating this factor remains the L.E.-cell test, which is a complex process involving the reaction of a component of the cell nucleus with the serum lupuserythematosus factor and subsequent phagocytosis of the altered nuclear material.5 Other methods for the detection of antinuclear antibodies have proved useful both clinically and in immunologic investigations. These include the identification of gamma globulin present on cell nuclei by measurement of its ability to decrease . . .
No takes yet. Share an insight, caveat, or question.
Scalettar et al. (1960) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: